BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statementAutoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
2
Gislaine Silveira Olm. Dermatology in Public Health Environments2018; : 823 doi: 10.1007/978-3-319-33919-1_40
3
Çetin Karaca. Viral Hepatitis: Chronic Hepatitis C2019; : 183 doi: 10.1007/978-3-030-03757-4_10
4
Umer Ansari, Lauren I. Henderson, Geraldine Stott, Karina Parr. Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planusJAAD Case Reports 2017; 3(1): 67 doi: 10.1016/j.jdcr.2016.12.005
5
Ashwani K. Singal, Krishna V.R. Venkata, Sarat Jampana, Fakhar-Ul Islam, Karl E. Anderson. Hepatitis C Treatment in Patients With Porphyria Cutanea TardaThe American Journal of the Medical Sciences 2017; 353(6): 523 doi: 10.1016/j.amjms.2017.03.007
6
Lucija Kuna, Jelena Jakab, Robert Smolic, George Y Wu, Martina Smolic. HCV Extrahepatic ManifestationsJournal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00049
7
Ayman Abdelmaksoud. Anti-HCV for porphyria cutanea tardaDermatologic Therapy 2017; 30(3): e12466 doi: 10.1111/dth.12466
8
Uyen Ngoc Mui, Christopher T. Haley, Ramya Vangipuram, Stephen K. Tyring. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and preventionJournal of the American Academy of Dermatology 2019; 81(1): 23 doi: 10.1016/j.jaad.2018.10.072
9
Nancy S. Handler, Marc Z. Handler, Matthew P. Stephany, Glenn A. Handler, Robert A. Schwartz. Porphyria cutanea tarda: an intriguing genetic disease and markerInternational Journal of Dermatology 2017; 56(6): e106 doi: 10.1111/ijd.13580
10
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of hepatitis C cure with antivirals: why test and treat?Future Microbiology 2019; 14(5): 425 doi: 10.2217/fmb-2019-0041
11
B Bruzzone, O Magnani, L Sticchi, P Canepa, E Rappazzo, G Icardi, M Setti. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapyJournal of Antimicrobial Chemotherapy 2017; 72(10): 2955 doi: 10.1093/jac/dkx222
12
Ankur Guliani, Krishna Jha, Divya Aggarwal, Bishan Dass Radotra, Atul Rana, Muthu Sendhil Kumaran. Blisters on the sun-exposed area: as a clue for underlying hepatitis C virus infectionPostgraduate Medical Journal 2019; 95(1120): 108 doi: 10.1136/postgradmedj-2018-136181
13
N. N. Potekaev, L. L. Karpov, O. V. Dolya, M. N. Markova. Late skin porphyria as a rare case of extrahepatic manifestations of chronic hepatitis C in a patient with a history of syphilisKlinicheskaya dermatologiya i venerologiya 2018; 17(5): 119 doi: 10.17116/klinderma201817051119
14
Mehmet Sayiner, Pegah Golabi, Freba Farhat, Zobair M. Younossi. Dermatologic Manifestations of Chronic Hepatitis C InfectionClinics in Liver Disease 2017; 21(3): 555 doi: 10.1016/j.cld.2017.03.010
15
Manasvi Gupta, Manik Aggarwal, Neetu Bhari. Acneiform eruptions: An unusual dermatological side effect of ribavirinDermatologic Therapy 2018; 31(5): e12679 doi: 10.1111/dth.12679
16
Massimo Galli, Giuseppe Monti, Piero Marson, Patrizia Scaini, Maurizio Pietrogrande, Marco Candela, Laura Castelnovo, Paola Faggioli, Paola Novati, Roberta Zani, Maria Teresa Mascia, Francesco Saccardo, Cesare Mazzaro, Piercarlo Sarzi-Puttini, Marco Sebastiani, Luca Quartuccio, Salvatore De Vita. Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndromeAutoimmunity Reviews 2019; 18(8): 778 doi: 10.1016/j.autrev.2019.06.008
17
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementAutoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
18
Yumiko Nagao, Kanae Kimura, Yuji Kawahigashi, Michio Sata. Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting AntiviralsClinical and Translational Gastroenterology 2016; 7(7): e179 doi: 10.1038/ctg.2016.37
19
Mohamed El Kassas, Mohamed Naguib Wifi, Reem Mahdy, Shimaa Afify, Enas Hafez, Yasmeen Abd El Latif, Marwa Ezzat, Adel El Tahan, Naglaa Youssef, Gamal Esmat. Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case seriesArab Journal of Gastroenterology 2017; 18(1): 39 doi: 10.1016/j.ajg.2017.02.003
20
Alejandro A. Gru, Andrea L. Salavaggione. Lichenoid and interface dermatosesSeminars in Diagnostic Pathology 2017; 34(3): 237 doi: 10.1053/j.semdp.2017.03.001
21
F.B. Oliveira, J.C. Boza, G.C. Pires, C.R. Barone, S.D. Rossi, M. Silva, R.R. Bonamigo. Direct-acting antiviral drugs are triggers for psoriasis: report of three casesInternational Journal of Dermatology 2018; 57(10): e95 doi: 10.1111/ijd.14137
22
Lina Maria Mejia. Oral Manifestations of Gastrointestinal DisordersAtlas of the Oral and Maxillofacial Surgery Clinics 2017; 25(2): 93 doi: 10.1016/j.cxom.2017.04.002
23
Lucija Virović Jukić, Dominik Kralj. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70728
24
Joana Rigor, Sara Almeida Pinto, Daniela Martins-Mendes. Porphyrias: A clinically based approachEuropean Journal of Internal Medicine 2019; 67: 24 doi: 10.1016/j.ejim.2019.06.014